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pro-apoptotic protein Bax after a yeast-based human 
hippocampal cDNA library screening. The yeast 
strain carrying the Bax gene was transformed with 
an episomal 2-micron plasmid that encodes the HA-
tagged FKBP2 gene. The resultant strain would allow 
co-expression of Bax and FKBP2 in yeast cells. The 
results presented here show that a protein involved in 
protein folding can play a role in protecting yeast cell 
from Bax-induced apoptosis.
Keywords Human FKBP2 · Yeast apoptosis · 
Human FKBP13 · Protein folding and apoptosis · 
FKBP2 and Bax
Introduction
FKPB13 is an endoplasmic reticulum (ER) chaperone 
(Tat et al. 2021); the FKBP2 gene encodes FKBP13 
(Boon et  al. 2009); its molecular function includes 
transport between trans-proline and cis-proline resi-
dues for appropriate folding of the protein in the 
lumen of the ER (Jeong et  al. 2017). FKBP13 has 
been reported to be upregulated through ER stress 
(Bush et  al. 1995) which is believed to be vital for 
the maintenance of ER protein homeostasis as part 
of the unfolded protein response (Jeong et al. 2017). 
ER stress could mediate the start and advancement 
of diseases (Kropski and Blackwell 2018). ER stress 
was linked to inducing apoptosis in alveoli type 2 
cells (Katzen et  al. 2019) and the differentiation of 
Abstract FK506-binding protein 2 (FKBP13) is a 
part of the immunophilin protein family involved in 
immunoregulation. It is also believed to operate as 
a factor in membrane cytoskeletal framework and 
as an ER chaperone. FKBP2 (FKBP13) and FKBP1 
(FKBP12), known as immunophilins, are binding 
proteins for rapamycin and FK506, which are immu-
nosuppressive drugs. It was suggested that immuno-
philin-like and immunophilin proteins play significant 
roles in regulating intracellular calcium and protein 
folding/sorting, acting as molecular chaperones. 
Within the 15 mammalian FKBPs known, FKBP1 is 
merely the only one proven to form complexes with 
rapamycin and FK506 in the cytosol and facilitate 
their T cells immunosuppressive effects, FKBP2 is 
a luminal protein of the endoplasmic reticulum (ER) 
and is reported to take part in protein folding in the 
ER. However, little is known about FKBP2 link with 
apoptosis (either as a pro or anti-apoptotic protein). In 
this study, FKPB2 protein was co-expressed with the 
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the myofibroblast and T cell (Kropski and Blackwell 
2018). FK506-binding protein 2 (FKBP2) is part of 
the immunophilin protein family. FKBP2 is involved 
in immunoregulation; it is also believed to operate as 
a factor in membrane cytoskeletal framework and ER 
chaperone (Kim et al. 2017). FK506-binding proteins 
(FKBPs) and cyclophilins bind to FK506 and cyclo-
sporine A (CsA) to form complexes that inhibit the 
protein phosphatase calcineurin that regulates T cell 
proliferation and also has a role in neuronal apoptosis 
(Nigam et al. 1993). Activation of T cells is prevented 
by FK506 and CsA, which are immune-suppressants. 
Because of their indirect association with immune 
suppression via calcineurin inhibition, FKBPs 
and cyclophilins are referred to as immunophilins 
(Nigam et  al. 1993). FKBP2 (FKBP13) and FKBP1 
(FKBP12), known as immunophilins, are binding 
proteins for rapamycin and FK506, which are immu-
nosuppressive drugs (Nigam et al. 1993).
The FKBPs and cyclophilins function as cis–trans 
prolyl isomerases, which have a profound role in 
protein folding (Edvardsson et  al. 2007). FKBP12 
(FKBP1) and FKBP13 (FKBP2) are two proteins with 
comparable molecular weight, 12 and 13 kDa. They 
share 43% similarity in their amino acid sequences. 
FKBP1 is cytosolic, whereas FKBP2 is membrane-
bound and resides in the ER. FKBP2 possesses a 
COOH-terminal RTEL motif and an NH2-terminal 
signal sequence, alleged to take part in ER retention 
and targeting of the protein to the ER (Walensky et al. 
1998). After being retained in the ER, FKBP2 binds 
to ER membranes with its 21 amino acid membrane-
binding domain (Nigam et al. 1993). FKBP2, like the 
immunoglobulin-binding protein (BiP), is thought 
to take part in protein folding and act as a molecular 
chaperone in the lumen of the ER (Padilla et al. 2003; 
Walensky et al. 1998). It has also been suggested that 
FKBP2 influences vesicular trafficking (Padilla et al. 
2003).
Folding of secreted proteins occurs in the ER. 
Reactive oxygen species (ROS) levels are elevated 
when there is a defect in protein folding within the 
ER; these elevated ROS levels can lead to defective 
electron transport chains causing hyper-activation 
of nicotinamide adenine dinucleotide phosphate H 
(NADPH) oxidase within the ER culminating in the 
triggering of programmed cell death (Akintade and 
Chaudhuri 2020c; Haynes et  al. 2004; Leadsham 
et  al. 2013). It can be speculated that, like binding 
immunoglobulin protein (BiP), FKBP2 protects 
the ER from ROS damage. FKBP2 may also play a 
part outside the ER, such as in cytoskeletal support 
of membranes (Walensky et  al. 1998). FK506, CsA 
and rapamycin, another immune-suppressant, prevent 
the growth of some strains of the yeast Saccharomy-
ces cerevisiae (Nielsen et  al. 1992). Yeast also has 
FK506-binding proteins, yFKBP12 and yFKBP13. 
Yeast strains lacking yFKBP12 are resistant to rapam-
ycin but are sensitive to FK506 (Nielsen et al. 1992). 
Immense rates of secretion and synthesis of immuno-
globulin (Ig) exposes plasma cells to huge endoplas-
mic reticulum (ER) stress (Jeong et al. 2017). FK506-
binding protein 13 protein has been linked to quality 
control that protects plasma cells from ER stress, 
which could trigger an associated apoptosis response 
(Jeong et  al. 2017). Protein homeostasis is vital for 
the existence of plasma cells; while the molecular 
mechanism is generally unknown, FKBP2 protein 
overexpression was reported to be present in long-
lived plasma cells from autoimmune mice (Jeong 
et al. 2017). This shows the need for an understanding 
of protein homeostasis.
Redox homeostasis is maintained by cells using 
stored antioxidant enzymes to mend oxidative dam-
age and neutralise excessive ROS levels produced by 
organelles within cells and external sources (Perrone 
et  al. 2008). If the concentrations of internal ROS 
continue to increase above a specific limit, it would 
invariably lead to oxidative stress leading to the 
accumulation of oxidised proteins, DNA, and lipids 
(Akintade and Chaudhuri 2020b; Drakulic et  al. 
2005). FKPB2 has not directly been linked to apop-
tosis. Higher FKBP13 protein expression has been 
seen in several fibrotic lung diseases (Li et al. 2021). 
FKBP13 knock out mice was reported to have ampli-
fied lung inflammation and heightened predisposi-
tion to alveoli type 2 cells apoptosis (Li et al. 2021). 
Lack of FKBP13 blocked late-stage fibrosis resolu-
tion because of increased apoptosis of lung epithelial 
cells induced by ER stress (Li et al 2021). However, 
according to Bush et al. (1994), the ER’s lumen is the 
initial site for correct folding and assembly of secre-
tory proteins and ER-bound trans-membrane pro-
teins. FKPB2 could be considered a molecular chap-
erone, which binds briefly to proteins that have been 
translocated into the ER and facilitated their folding. 
FKBP2 gene has been linked to obsessive osteopo-
rosis (Kim et al. 2017) and type 2 diabetes (Lu et al. 
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2008). FKBP2 was also reported to be expressed in 
tissues that are susceptible to hyperplasia in MEN1 
(multiple endocrine neoplasia type-1) patients; none-
theless, FKBP2 was excluded in the mutation analysis 
of MEN1 tumours as a possible biomarker gene for 
MEN1 (Kim et  al. 2017). The anti-apoptotic prop-
erty of FKBP2 was studied in this research along 
with Bcl-xL, a Bcl-2 protein family, which is anti-
apoptotic. FKBPs are a distinct group of chaperones 
located in a broad diversity of organisms (Somarelli 
et al. 2008). Some of the cellular function they carry 
out include apoptosis modulation, protein folding, 
assembly of histone, cytokines regulation, bind-
ing to nucleic acid, and steroid receptor complexes 
transport (Somarelli et  al. 2008). Several of these 
roles involve certain domains which adjust to defi-
nite tertiary forms. Humans, FKBP2 have adjustable 
amounts of FKBP domains which are linked with the 
ER (Somarelli et al. 2008).
Some novel genes were discovered to salvage Bax-
induced apoptosis in screening the human hippocam-
pal cDNA library in yeast, as patented and described 
previously (Publication number: 20090258794) 
(Chaudhuri 2009). FKBP2 (a gene involved in pro-
tein folding) gene was one of the genes identified 
and has been chosen for further investigation in this 
study to corroborate its role in apoptosis inhibition. 
Yeast strain carrying one copy of integrated Bax 
gene leu2::LEU2-Bax was transfected with episo-
mal (2-micron) plasmid, which encodes FKBP2 and 
Bcl-xL genes (HA-tagged) (supplementary informa-
tion). The resultant strains leu2::LEU2-Bax pSYE/
FKBP2-HA allows the co-expression of Bax and 
FKBP2 in the yeast strain, while leu2::LEU2-Bax 
pSYE/Bcl-xL-HA allows the co-expression of Bax 




The yeast strain W303-1A Mata (MATa ade2-1 
ura3-1 his3-11 trp1-1 leu2-3 leu2-112 can1-100) 
(ATCC #208,352) is auxotrophic for ADE2, HIS3, 
LEU2, TRP1 and URA3. New yeast strains were cre-
ated by transforming integrative plasmids (Supporting 
Information, Sects. 1, 2, 3), which would express Bax 
from the GAL1 promoter or episomal plasmid expres-
sion FKBP2 or Bcl-xL gene on PGK1 promoter.
Yeast transformation
Plasmid bearing Bax gene expression cassettes under 
the control of the galactose-inducible GAL1 promoter 
(GAL1p; see Supporting Information, Sects.  1) was 
used for genomic integration at the LEU2 chromo-
somal loci of the yeast strain to yield strains that con-
tain one copy of Bax,—leading to the generation of 
leu2::LEU2-Bax yeast strain. And an episomal plas-
mid bearing FKBP2 or Bcl-xL gene expression cas-
settes on a PGK1 promoter, creating leu2::LEU2-Bax 
pSYE/FKBP2-HA, leu2::LEU2-Bax pSYE/Bcl-xL-
HA, and leu2::LEU2-Bax pSYE-HA (negative con-
trol) yeast strains. The transformation was carried out 
using a published protocol (Kawai et al. 2010).
Detection of dead cells with phloxine B dye
Determining cell viability is one of the most com-
mon methods for measuring the impact of differ-
ent types of irritants or stressors in toxicity studies. 
Viability shows the proportion of live cells in the 
entire populace. Phloxine B (a red dye) is water-sol-
uble and could be used to stain dead cells of many 
cells, including yeasts (Saccharomyces cerevisiae). 
Cell death was assessed by staining cells with the red 
dye phloxine B (Sigma, P-4030-25G) (Kwolek-Mirek 
and Zadrag-Tecza 2014). Live cells expel the dye, 
whereas it is accumulated in dead cells. This can be 
observed by fluorescence microscopy. Staining exper-
iments were performed exactly as published earlier 
(Derf et al. 2018).
Detection of ROS with dihydroethidium
ROS are biological products from the normal metab-
olism of oxygen. ROS plays an essential role in cell 
signalling. Nonetheless, ROS levels could increase 
significantly throughout oxidative stress and accu-
mulate, resulting in significant damage to the cell. 
Fluorimetric ROS assay kit uses a unique ROS sensor 
to quantify ROS in cells. AAT Bioquest Fluorimetric 
Intracellular Total ROS Activity Assay Kit (#22,901) 
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was used for measuring ROS. Experiments were per-
formed as published earlier (Derf et al. 2018).
Quantifying mitochondrial membrane potential with 
the JC-10 dye
Mitochondria are the critical powerhouse of cells, and 
it plays crucial roles in cell proliferation and apop-
tosis. Mitochondrial membrane potential assay kit 
detects the mitochondrial membrane potential in liv-
ing cells. AAT Bioquest JC-10 mitochondrial mem-
brane potential assay kit (#22,800) uses water-soluble 
JC-10 to determine MMP quantitively. Experiments 
were conducted as per the published protocol (Derf 
et al. 2018).
Staining with Hoechst dye for monitoring live cells
Hoechst 33,258 (Thermo Fisher Scientific; #H21491) 
is a nucleic acid stain widely used to detect live cells. 
When bound to double-stranded DNA, the dye emits 
blue fluorescence. Staining with the dye was per-
formed as described earlier (Derf et al. 2018).
Assessing nuclear DNA fragmentation via the 
TUNEL assay
AAT Bioquest TUNEL apoptosis assay kit (#22,844) 
was used to detect nuclear DNA fragmentation 
(NDF). The assays were performed as described ear-
lier (Derf et al. 2018).
Western blotting
Western blotting was carried out using standard pro-
tocols (Von Der Haar 2007), using primary antibodies 
specific to c-Myc (Thermo Scientific, #MA 1–980) 
and HA-tag (Proteintech, #51,064–2-AP) or β-actin 
(Proteintech; #60,008–1-Ig).
Results and discussion
Co-expression of Bax on GAL1 promoter with 
FKBP2 and Bcl-xL on PGK1 promoter
In this study, FKPB2 protein was co-expressed with 
the pro-apoptotic protein Bax. The yeast strain carry-
ing the Bax gene (leu2::LEU2-Bax) was transformed 
with an episomal 2-micron plasmid that encodes the 
HA-tagged FKBP2 gene (see supplementary infor-
mation). The resultant strain leu2::LEU2-Bax pSYE/
FKBP2-HA would allow co-expression of Bax 
and FKBP2 in yeast cells. Bax is under the control 
of the GAL1 promoter, while the PGK1 promoter 
drives FKBP2 expression. Figure 1 show the growth 
assays (solid and liquid media) of the leu2::LEU2-
Bax pSYE/FKBP2-HA strain along with positive 
(leu2::LEU2-Bax pSYE/Bcl-xL-HA) and negative 
(leu2::LEU2-Bax pSYE-HA) controls. The posi-
tive control contains the Bcl-xL gene, a known anti-
apoptotic gene, while the negative control has no 
gene insertion (just the vector). Figure  1 shows that 
the yeast strains containing pSYE/FKBP2-HA and 
pSYE/Bcl-xL-HA along with the Bax gene grew in 
both media, unlike the yeast strain containing the neg-
ative control vector gene, which did not grow. Further 
assays were carried out as shown in Fig. 2 and Fig. 3 
to measure apoptosis hallmark in the respective stra
ins.
Phloxin B assay (death assay) shown in Fig. 2 (A 
and B) measured the percentage of cell death after 
Bax protein expression with either FKBP2 and Bcl-
xL compared with the strain containing the vector 
gene (negative control). Phloxin B dye stains dead 
cells while live cells expel the dye; the negative con-
trol has significantly (p < 0.05) more death than cells 
containing FKPB2 and Bcl–xL genes. However, the 
difference between FKPB2 and Bcl-xL is not signifi-
cant (p > 0.05). This result suggests that FKBP2, sim-
ilar to Bcl-xL (positive control) rescues Bax-induced 
apoptosis. This result corroborates the growth assay 
in Fig. 1, which show cell growth in the yeast strains 
containing pSYE/FKBP2-HA and pSYE/Bcl-xL-HA 
but no growth in yeast cells containing leu2::LEU2-
Bax pSYE-HA. After the growth assay and death 
assay results, a live assay (Fig.  2C) was performed 
along with mitochondrial membrane potential assay 
(MMP) (Fig.  2D). Hoechst 33,342 dye stains live 
cells (Fig. 2C), the negative control has the least live 
cells compared to FKBP2 and Bcl-xL. Figure  2D 
shows the measurement of MMP; again, yeast cells 
contain FKBP2 and Bcl-xL have higher MMP than 
the negative control strain. The mitochondrial is the 
cell’s powerhouse; it produces adenosine triphosphate 
(ATP). When the mitochondrial is damaged, it could 
trigger cell death via apoptosis; essentially, mitochon-
dria membrane potential (MMP) is needed for ATP 
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production (Zorova et  al. 2018). Decrease in MMP 
amount to ATP reduction. When a cell reaches a point 
of no return, the cell loses its MMP and become com-
mitted to death. A prolonged plunge or increase of 
MMP standard levels could provoke an undesirable 
decline in cell viability and could result in different 
pathological conditions. The mitochondria is crucial 
for maintaining cellular viability and health.
Figure 3 show the ROS and TUNNEL assays and 
western blotting of the proteins. The ROS produced 
by the strains was measured; the negative control 
produced the higher ROS, followed by the strain 
with FKBP2 and then the positive control (Fig. 3A). 
If ROS level is very high, it could destroy proteins, 
membranes, nucleic acids, organelles, and lipids; 
this could, in turn, trigger the activation of apopto-
sis (programmed cell death) processes (Ghosh et  al. 
2018). TUNNEL assay (Fig.  3B and C) measures 
DNA fragmentation, one of the hallmarks of apop-
tosis. The strain with empty plasmid has the high-
est DNA fragmentation than the strain with FKBP2 
and Bcl-xL; this suggests the rescue of yeast cells 
from Bax-induced apoptosis. The western blot shows 
the presence of the respective protein after their 
expression.
In this study, the expression of FKBP2 protein 
was shown to rescue Bax-induced apoptosis. FKBP2 
expression was reported to be generated mainly in the 
endoplasmic reticulum lumen after treatment with 
an ER stressor (i.e. tunicamycin) (Jeong et al. 2017). 
Also, suppressing of FKBP2 expression was said to 
have led to an induction of molecules involved in 
the terminal unfolded protein response (UPR) and 
ER stress–linked apoptosis. FKBP2 could lower ER 
stress, but FKBP2 knockdown had a differing effect 
(Jeong et  al. 2017). FKBPs (FK506-binding pro-
teins) are a group of enzymes that has peptidyl-prolyl 
cis–trans isomerase (PPIase or rotamase) activities 
(Harrar et  al. 2001). Besides the enzymatic activity, 
the PPIase domain has a hydrophobic core with a 
drug-binding compact that allows FKBP to operate as 
an immunophilin (Jeong et  al. 2017). Within the 15 
mammalian FKBPs known, FKBP12, a typical mem-
ber is merely the only one proven to form complexes 
with rapamycin and FK506 in the cytosol and facili-















Comparing the growth of yeast strains 
Bax/FKBP2, Bax/Bcl xL and Bax– in minimal 
liquid SG medium that contains galactose
Bax(LEU2)::FKBP2 Bax(LEU2):: – Bax Bcl  xL
Fig. 1  A and B Growth of yeast strains in solid agar plates 
over 72  h, in glucose-containing minimal medium (SD), and 
galactose-containing minimal medium (SG). The 4 transfor-
mants on the upper half of the two plates are leu2::LEU2-Bax 
pSYE/FKBP2-HA (A) and leu2::LEU2-Bax pSYE/Bcl-xL-HA 
(B) transformants (1), containing an episomal 2µ-plasmid plas-
mid that encodes the HA-tagged FKBP2 (A) and Bcl-xL (B) 
genes and a Bax expression cassette integrated at the LEU2 
locus. The 4 transformants, in the lower half of the plates (A) 
and (B), is leu2::LEU2-Bax pSYE-HA (2) transformants which 
contain the Bax expression cassette and an empty plasmid. C 
Growth of yeast cells, leu2::LEU2-Bax pSYE/FKBP2-HA and 
leu2::LEU2-Bax pSYE/Bcl-xL-HA, in minimal liquid medium 
containing galactose, throughout 48 h along with negative con-
trol strain. A two-tailed paired sample t-test show, statistically, 
that there was a significant difference (p < 0.05) compared to 
the control, but the difference between FKPB2 and Bcl-xL is 
not significant (p > 0.05)
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et al 1989; Schreiber 1991). These complexes (rapa-
mycin–FKBP12 and FK506–FKBP12) mainly inhibit 
the mammalian target of rapamycin (mTOR) and cal-
cineurin (Jeong et al. 2017).
FKBP2 (FKBP13), a known immunophilin, is 
binding proteins for rapamycin and FK506, which are 
immunosuppressive drugs. The cells co-expressing 
FKBP2 with Bax grew on galactose-containing SG 
agar plates (Fig.  1A), likewise cells co-expressing 
Bcl-xL with Bax (Fig.  1B), but the control strain 
did not. FKBP2, an ER luminal protein, was able to 
rescue Bax-induced apoptosis. The growth curve 
(Fig. 1C) and death assay (Fig. 2A) corroborated that 
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Mitochondrial Membrane Potenal of yeast 
cells Bax/FKBP2, Bax/Bcl xL & Bax–, grown in 
galactose for 48 h
Fig. 2  A The percentage cell death in strains leu2::LEU2-Bax 
pSYE/FKBP2-HA, leu2::LEU2-Bax pSYE/Bcl-xL-HA and 
control leu2::LEU2-Bax pSYE-HA, after growth in galactose 
for 48 h. B Dead cells stained with phloxine B are shown in. 
A two-tailed paired sample t-test show, statistically, that there 
was a significant difference (p < 0.05) compared to the control, 
but the difference between FKPB2 and Bcl-xL is not signifi-
cant (p > 0.05). (C) Visualisation of yeast cells that co-express 
Bax and FKBP2 and Bcl-xL or Bax alone, after staining with 
Hoechst 33,342 dye. D Quantification of the mitochondrial 
membrane potential of yeast strains, leu2::LEU2-Bax pSYE/
FKBP2-HA which co-expresses Bax and FKBP2, leu2::LEU2-
Bax pSYE/Bcl-xL-HA which co-expresses Bax and Bcl-xL, 
and leu2::LEU2-Bax pSYE-HA which expresses Bax alone, 
using a fluorescent plate reader. A two-tailed paired sample 
t-test shows that there was a significant difference (p < 0.05) 
compared to the control, but the difference between FKPB2 
and Bcl-xL is not significant (p > 0.05)
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Figure  1 shows the growth of yeast cells carrying 
FKBP2 in the presence of full-blown Bax expression. 
All immunophilins possess cis–trans prolyl isomerase 
activity. The cis–trans prolyl isomerases play a fun-
damental role in the correct folding of proteins. Yeast 
FKBP2 (yFKBP2) is 64% similar in protein sequence 
to human FKBP2 (hFKBP2), whereas yFKBP1 is 
51% similar to hFKBP1 (Nielsen et al. 1992). FKBP2 
is a luminal protein of the ER and is reported to take 











TUNEL assay of yeast cells Bax/FKBP2, 
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1        2        3      
(-) Bcl-x(L) FKBP2
Fig. 3  A Measurement of ROS produced in the yeast strains 
leu2::LEU2-Bax pSYE/FKBP2-HA, leu2::LEU2-Bax pSYE/
Bcl-xL-HA and leu2::LEU2-Bax pSYE-HA, A two-tailed 
paired sample t-test show that there was a significant difference 
(p < 0.05) compared to the control, but the difference between 
FKPB2 and Bcl-xL was not significant (p > 0.05). B TUNEL 
assay comparing the nuclear DNA fragmentations in yeast 
strains leu2::LEU2-Bax pSYE/FKBP2-HA, leu2::LEU2-Bax 
pSYE/Bcl-xL-HA and leu2::LEU2-Bax pSYE-HA. The cells 
FKBP and Bcl-xL have lower nuclear DNA fragmentation 
compared to leu2::LEU2-Bax pSYE-HAstrain. A two-tailed 
paired sample t-test show that there was a significant difference 
(p < 0.05) compared to the control, but the difference between 
FKPB2 and Bcl-xL is not significant (p > 0.05). C Represent 
the microscopic image of cells after tunel assay, leu2::LEU2-
Bax pSYE/FKBP2-HAand leu2::LEU2-Bax pSYE/Bcl-xL-
HA. D Western blot to monitor the presence of Bax in yeast 
cells that express only Bax and in cells that co-express Bax 
together with FKBP2 and, Bcl-xL. A 10  µg of total cellular 
proteins in cell lysates were loaded onto each lane, and the blot 
was probed with an antibody that recognises the c-myc-tag, 
Actin, and HA-tag
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FKBPs are a distinct group of chaperones located in 
a broad diversity of organisms (Somarelli et al. 2008). 
Some of the cellular function they carry out include 
apoptosis modulation, protein folding, assembly of 
histone, cytokines regulation, binding to nucleic acid, 
and steroid receptor complexes transport (Somarelli 
et  al. 2008). Several of these roles involve certain 
domains which adjust to definite tertiary forms. 
Humans, FKBP2 have adjustable amounts of FKBP 
domains which are linked with the ER (Somarelli 
et al. 2008). FK506-binding protein 13 (FKBP13) has 
approximately 43 nucleotides and 51% amino acid 
sequence homology with FKBP12 (Jin et  al. 1991). 
The drug-binding site amino acid residues of FKBP12 
is conserved in FKBP13 (Jin et  al. 1991). However, 
FK506–FKBP13 complex was not found (in vitro) to 
substantially inhibit calcineurin (Dumont 2000), and 
no known function of a rapamycin–FKBP13 complex 
was reported (Jeong et  al. 2017). FKBP13 has been 
said to be located in the ER lumen in the canine’s 
pancreatic cells and stimulated by ER stressors (Bush 
et al. 1994; Nigam et al. 1993).
Staining with phloxine B and Hoechst dye 
showed the extent of death and life in the cells rep-
resented in Fig.  2A, B, and C, respectively. The 
figure shows death of cells due to Bax expression 
and life resulting from FKBP2’s rescuing cells. 
A similar observation was also recorded for Bcl-
xL. Significantly, less cell death occurred in the 
strain Bax(LEU2)FKBP2 compared to the strain 
Bax(LEU2)—, which expressed Bax alone, but 
the difference between Bax(LEU2)FKBP2 and 
Bax(LEU2)Bcl-xL is not significant. FKBP2 has 
been recognised in coarse microsomal sub-cellu-
lar portions and is more concentrated in samples 
holding luminal proteins of the ER (Walensky 
et  al. 1998). Expression of FKBP2 is upregulated 
in response to heat shock and during accrual of 
unfolded/aggregated proteins in the ER (Walensky 
et al. 1998). ER stress can easily activate unfolded 
protein response (UPR) as an adaptive tactic to 
maintain viability in the process of re-establishing 
the homeostasis of protein homeostasis (Todd et al. 
2008). Nevertheless, in the presence of excessive 
ER stress outside the capability of UPR adaptive 
strategy, terminal UPR is then initiated, and apop-
tosis is executed (Jeong et  al. 2017). Furthermore, 
expression of a DNA damage-inducible transcript 
3 (C/EBP homologous protein (CHOP)), which 
is a pro-apoptotic transcription factor, is a typi-
cal indicator for terminal UPR preceding apoptosis 
(Marciniak et al. 2004). Thus, there might be a link 
between ER stress-mediated apoptosis and secre-
tory load increase (Puthalakath et al. 2007).
The difference in ROS production between the 
strains is significant. The strain expressing Bax 
alone produces far more ROS than the strains co-
expressed FKBP2 and Bcl-xL (Fig.  3A). TUNEL 
assay (Fig. 3B and  C), ROS measurement (Fig. 3A) 
and mitochondrial potential quantification (Fig.  2D) 
indicate that FKBP2 can rescue cells from Bax’s tox-
icity. Figure 3D shows Western blots to confirm the 
co-expression of FKBP2 and Bax and shows that the 
proteins were expressed. This is probably the first 
time that FKBP2 has been linked to apoptosis as 
a Bax inhibitory protein. It has been suggested that 
FKBP2 may function as ER molecular support, cata-
lysing the gathering and/or folding of proteins in the 
ER (Walensky et al. 1998). This function could also 
involve correcting the folding of misfolded proteins 
or preventing misfolding of proteins. Bax that delo-
calised from the cytosol to the mitochondria to exert 
its toxic effects may do so in a conformational form 
that is toxic for the cells (Akintade and Chaudhuri 
2020a). It may be that FKBP2 somehow prevents this 
toxic conformation of Bax from being formed.
X-box-binding protein 1 (XBP1) is one of the 
three branches of the UPR. XBP1 primarily serves to 
stimulate the enlargement of the ER (Iwakoshi et al. 
2003). Because it functions as a transcription factor 
to generate molecular chaperones that improve ER-
associated degradation (ERAD) and protein folding 
capacity when induced (Jeong et  al. 2017). In the 
event of aggregation, it enables detection by ubiquitin 
ligases, which results in the delivery of the substrates 
ubiquitinated to the proteasome (Shiber and Ravid 
2014). This suggests that the chaperones perform a 
vital role in the clearance by the ubiquitin–protea-
some system (UPS) of the incurably misfolded pro-
teins. The exact role of FKBP13 in anti-apoptotic 
activity is unknown. In this study, the anti-apoptotic 
function of FKBP13 was investigated through Bax-
induced apoptosis in the yeast cell. The result shows 
that FKBP13 could play a crucial role in preventing 
Bax-induced apoptosis in yeast, which may play a 
part in the continuous survival of cells and disease 
development, progression, and treatment.
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Conclusions
In this study, specific trends in the yeast model of 
FKBP2 ability to rescue Bax’s inherent toxicity were 
observed. These results suggest the involvement of 
FKBP2 in apoptosis. FKBP2 has not been directly 
implicated in apoptosis (either as a pro or anti-apoptotic 
protein) before; the findings presented here show that 
a protein involved in protein folding can play a role in 
rescuing apoptosis. This study showed that FKBP2 is 
anti-apoptotic, negating the toxic effects of human Bax 
protein. This connects the protein folding pathway in 
apoptotic processes. It is known that some toxic pro-
teins usually aggregate before they exert their toxicity 
on cells. There is a strong argument for the involvement 
of proteins in the protein folding pathway, which could 
prevent aggregation. This sort of action could be impor-
tant to the survival of cells and tissues where the aggre-
gation occurs, such as neurodegenerative diseases. Fur-
ther studies to elucidate the pathways involved will be 
of vital importance. FKBP2 possibly acts as a molecu-
lar chaperone that prevents aggregation and misfolding 
of proteins in the endoplasmic reticulum, reducing pro-
teotoxic stress. This study suggests that FKBP2 play a 
cytoprotective role when co-expressed with Bax protein 
in yeast cells. However, the mechanism underlying this 
anti-apoptotic characteristic of FKBP13 remains largely 
unknown and needed to be explored further.
Author contributions DA performed all the experiments. 
BC coordinated the study. BC and DA wrote the manuscript.
Funding Funds from De Montfort and Leeds Beckett Univer-
sity supported this work.
Data availability All data generated or analysed during this 
study are included in this published article [and its supplemen-
tary information files].
Declarations 
Conflict of interest The authors declare no competing inter-
ests.
Open Access This article is licensed under a Creative Com-
mons Attribution 4.0 International License, which permits 
use, sharing, adaptation, distribution and reproduction in any 
medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Crea-
tive Commons licence, and indicate if changes were made. The 
images or other third party material in this article are included 
in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not 
included in the article’s Creative Commons licence and your 
intended use is not permitted by statutory regulation or exceeds 
the permitted use, you will need to obtain permission directly 
from the copyright holder. To view a copy of this licence, visit 
http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
References
Akintade DD, Chaudhuri B. Apoptosis, induced by human 
α-synuclein in yeast, can occur independent of functional 
mitochondria. Cells. 2020a;9(10):2203.
Akintade DD, Chaudhuri B. The effect of copy number on 
α-synuclein’s toxicity and its protective role in Bax-
induced apoptosis, in yeast. Biosci Rep. 2020b; 40(9).
Akintade DD, Chaudhuri B. Sensing the generation of intracel-
lular free electrons using the inactive catalytic subunit of 
cytochrome P450s as a sink. Sensors. 2020c;20(14):4050.
Boon K, Bailey NW, Yang J, Steel MP, Groshong S, Kervitsky 
D, ..., Schwartz DA. Molecular phenotypes distinguish 
patients with relatively stable from progressive idiopathic 
pulmonary fibrosis (IPF). PloS One. 2009; 4(4): e5134.
Bush K, Hendrickson B, Nigam S. Induction of the FK506-
binding protein, FKBP13, under conditions which mis-
fold proteins in the endoplasmic reticulum. Biochem J. 
1994;303(3):705–8.
Bush K, Hendrickson B, Nigam S. Induction of the FK506-
binding protein, FKBP13, under conditions which mis-
fold proteins in the endoplasmic reticulum. Biochem J. 
1995;305(3):1031.
Chaudhuri B (2009) Apoptosis Methods, Genes and Proteins. 
20090258794, Justia patents. Available: https:// paten ts. 
justia. com/ patent/ 20090 258794.
Derf A, Mudududdla R, Akintade D, Williams IS, Abdullaha 
M, Chaudhuri B, Bharate SB. Nonantioxidant tetrameth-
oxystilbene abrogates α-synuclein-induced yeast cell 
death but not that triggered by the Bax or βA4 Peptide. 
ACS Omega. 2018;3(8):9513–32.
Drakulic T, Temple MD, Guido R, Jarolim S, Breitenbach M, 
Attfield PV, Dawes IW. Involvement of oxidative stress 
response genes in redox homeostasis, the level of reactive 
oxygen species, and ageing in Saccharomyces cerevisiae. 
FEMS Yeast Res. 2005;5(12):1215–28.
Dumont FJ. FK506, an immunosuppressant targeting calcineu-
rin function. Curr Med Chem. 2000;7(7):731–48.
Edvardsson A, Shapiguzov A, Petersson UA, Schröder WP, 
Vener AV. Immunophilin AtFKBP13 Sustains all pep-
tidyl− prolyl isomerase activity in the thylakoid lumen 
from Arabidopsis thaliana deficient in AtCYP20-2. Bio-
chemistry. 2007;46(33):9432–42.
Ghosh N, Das A, Chaffee S, Roy S, Sen CK. Reactive oxygen 
species, oxidative damage and cell death. In Immunity 
and inflammation in health and disease. Elsevier; 2018. p. 
45–55.
Harding MW, Galat A, Uehling DE, Schreiber SL. A receptor 
for the immuno-suppressant FK506 is a cis–trans pepti-
dyl-prolyl isomerase. Nature. 1989;341(6244):758–60.
 Cell Biol Toxicol
1 3
Harrar Y, Bellini C, Faure J-D. FKBPs: at the cross-
roads of folding and transduction. Trends Plant Sci. 
2001;6(9):426–31.
Haynes CM, Titus EA, Cooper AA. Degradation of misfolded 
proteins prevents ER-derived oxidative stress and cell 
death. Mol Cell. 2004;15(5):767–76.
Iwakoshi NN, Lee AH, Glimcher LH. The X-box binding pro-
tein-1 transcription factor is required for plasma cell dif-
ferentiation and the unfolded protein response. Immunol 
Rev. 2003;194(1):29–38.
Jeong M, Jang E, Choi SS, Ji C, Lee K, Youn J. The function 
of FK506-binding protein 13 in protein quality control 
protects plasma cells from endoplasmic reticulum stress-
associated apoptosis. Front Immunol. 2017;8:222. https:// 
doi. org/ 10. 3389/ fimmu. 2017. 00222.
Jin Y-J, Albers MW, Lane WS, Bierer BE, Schreiber SL, Bura-
koff SJ. Molecular cloning of a membrane-associated 
human FK506-and rapamycin-binding protein, FKBP-13. 
Proc Natl Acad Sci. 1991;88(15):6677–81.
Katzen J, Wagner, BD, Venosa A, Kopp M, Tomer Y, Russo 
SJ, ..., Mulugeta S. An SFTPC BRICHOS mutant links 
epithelial ER stress and spontaneous lung fibrosis. JCI 
Insight. 2019; 4(6).
Kawai S, Hashimoto W, Murata K. Transformation of Sac-
charomyces cerevisiae and other fungi: methods and 
possible underlying mechanism. Bioengineered Bugs. 
2010;1(6):395–403.
Kim K-H, Yeo S-G, Yoo BC, Myung JK. Identification 
of calgranulin B interacting proteins and network 
analysis in gastrointestinal cancer cells. PloS One. 
2017;12(2):e0171232.
Kropski JA, Blackwell TS. Endoplasmic reticulum stress 
in the pathogenesis of fibrotic disease. J Clin Investig. 
2018;128(1):64–73.
Kwolek-Mirek M, Zadrag-Tecza R. Comparison of methods 
used for assessing the viability and vitality of yeast cells. 
FEMS Yeast Res. 2014;14(7):1068–79.
Leadsham JE, Sanders G, Giannaki S, Bastow EL, Hutton R, 
Naeimi WR, ..., Gourlay CW. Loss of cytochrome c oxi-
dase promotes RAS-dependent ROS production from 
the ER resident NADPH oxidase, Yno1p, in yeast. Cell 
Metab. 2013; 18 (2): 279-286.
Li X, Montesi SB, Zhang Y. FKBP13: a new player on the 
block in endoplasmic reticulum stress and lung fibrosis. 
In: American Thoracic Society; 2021.
Lu H, Yang Y, Allister EM, Wijesekara N, Wheeler MB. The 
identification of potential factors associated with the 
development of type 2 diabetes: a quantitative proteomics 
approach. Mol Cell Proteomics. 2008;7(8):1434–51.
Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, 
Jungreis R, ..., Ron D. CHOP induces death by promot-
ing protein synthesis and oxidation in the stressed endo-
plasmic reticulum. Genes & development. 2004; 18(24): 
3066-3077.
Nielsen JB, Foor F, Siekierka JJ, Hsu M-J, Ramadan 
N, Morin N, ..., Chrebet G. Yeast FKBP-13 is a 
membrane-associated FK506-binding protein encoded by 
the nonessential gene FKB2. Proc Natl Acad Sci. 1992; 
89(16): 7471-7475.
Nigam S, Jin Y, Jin M, Bush K, Bierer B, Burakoff S. Local-
ization of the FK506-binding protein, FKBP 13, to 
the lumen of the endoplasmic reticulum. Biochem J. 
1993;294(2):511–5.
Padilla PI, Chang M-J, Pacheco-Rodriguez G, Adamik R, Moss 
J, Vaughan M. Interaction of FK506-binding protein 13 
with brefeldin A-inhibited guanine nucleotide-exchange 
protein 1 (BIG1): effects of FK506. Proc Natl Acad Sci. 
2003;100(5):2322–7.
Perrone GG, Tan S-X, Dawes IW. Reactive oxygen species and 
yeast apoptosis. Biochim Biophys Acta (BBA)-Mol Cell 
Res. 2008;1783(7):1354–68.
Puthalakath H, O’Reilly LA, Gunn P, Lee L, Kelly PN, Hun-
tington ND, ..., Motoyama N. ER stress triggers apoptosis 
by activating BH3-only protein Bim. Cell. (2007); 129(7): 
1337-1349.
Schreiber SL. Chemistry and biology of the immunophi-
lins and their immunosuppressive ligands. Science. 
1991;251(4991):283–7.
Shiber A, Ravid T. Chaperoning proteins for destruction: 
diverse roles of Hsp70 chaperones and their co-chaper-
ones in targeting misfolded proteins to the proteasome. 
Biomolecules. 2014;4(3):704–24.
Somarelli J, Lee S, Skolnick J, Herrera R. Structure‐based clas-
sification of 45 FK506‐binding proteins. Proteins Struct 
Funct Bioinform. 2008;72(1):197–208.
Tat V, Ayaub EA, Ayoub A, Vierhout M, Naiel S, Padwal MK, 
..., Revill SD. FK506-binding protein 13 expression is 
upregulated in interstitial lung disease and correlated with 
clinical severity. a potentially protective role. Am J Respir 
Cell Mol Biol. 2021; 64(2): 235–246.
Todd DJ, Lee A-H, Glimcher LH. The endoplasmic reticulum 
stress response in immunity and autoimmunity. Nat Rev 
Immunol. 2008;8(9):663–74.
Von Der Haar T. Optimized protein extraction for quantitative 
proteomics of yeasts. PloS One. 2007; 2(10).
Walensky LD, Gascard P, Field ME, Blackshaw S, Conboy 
JG, Mohandas N, Snyder SH. The 13-kD FK506 bind-
ing protein, FKBP13, interacts with a novel homologue of 
the erythrocyte membrane cytoskeletal protein 4.1. J Cell 
Biol. 1998;141(1):143–53.
Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner 
IB, Jankauskas SS, ..., Juhaszova M. Mitochondrial mem-
brane potential. Anal Biochem. 2018; 552: 50-59.
Publisher’s note Springer Nature remains neutral with regard 
to jurisdictional claims in published maps and institutional 
affiliations.
